Trending Stories on Eyewire+

Trending Stories on Eyewire+


Opthea Publishes Phase 2b Trial Data for Wet AMD

Opthea announced new data from the phase 2b clinical trial using sozinibercept to treat wet age-related macular degeneration (AMD). The results were published in the peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging (OSLI) Retina. Read More


Staar Surgical Announces Leadership Changes

Staar Surgical announced that Stephen C. Farrell, current Lead Independent Director of the Staar Board of Directors, has been appointed President and CEO, effective February 26, 2025. He is replacing Tom Frinzi,?current President and CEO, who will remain with the company in an advisory role through January 2026. Read More


Altris AI Launches Advanced Optic Disc Analysis for Glaucoma

Altris AI, a provider of AI?OCT scan analysis for the detection?of a?range of retina pathologies and biomarkers, announced the launch of?an advanced glaucoma 'Optic Disc Analysis' module. Read More


EyewireTV | 2.26.2025


Alcon launches the first DSLT device in thee US; thee FDA approves an expanded label for Astellas Pharma's?geographic atrophy drug Izervay; and New World Medical receives FDA clearance?for the VIA360?Surgical System.?Click here to check it out!


Latest In Podcasts


Technology in the Contact Lens Space

In part two of this podcast, Darryl Glover Jr., OD, invites Britt E. Gustafson, OD, and Selina R. McGee, OD, FAAO, to share considerations when presenting contact lens options to patients—focusing on chair time, comfort, and cost. They explain how Alcon WaterInnovations??technology allows them to address patient needs and focus on comfort in contact lens wear. Click here to catch the latest episode.


Eyewire News: The Podcast

Oculus?launches new myopia software on its Pentacam?AXL; the first clinical polygenic risk score test for glaucoma in the US is launched; and Virtual Vision Health releases visual acuity testing on its VR platform. Catch the latest episodes here!


Latest in Subspecialties:

CATARACT: Glaukos Announces FDA Acceptance of NDA Submission for Epioxa

REFRACTIVE: Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine

GLAUCOMA: Nicox Announces New Data from the NCX 470 Mont Blanc Trial, Provides Development Updates

RETINA: Formycon Receives Approval in the UK for Eylea Biosimilar

OPTOMETRY: Alcon Announces US Launch of Systane PRO PF for Dry Eye Relief


Thank you for reading! We'll be back next week with another edition of?Eyewire+ Weekly Digest. For the most up to date news, please visit us at Eyewire+.


要查看或添加评论,请登录

Eyewire+的更多文章